CDK2 and intrahepatic cholangiocarcinoma: Our study implied that YTHDF2 plays a critical role in accelerating the cell cycle from G1 to S stage via the activation of cyclin E‐CDK2 or cyclin D‐CDK4 complexes, thereby promoting the proliferation of ICC.